Literature DB >> 21804899

The Akt pathway is involved in rapid ischemic tolerance in focal ischemia in Rats.

Xuwen Gao1, Hanfeng Zhang, Gary Steinberg, Heng Zhao.   

Abstract

Although the protective mechanisms of delayed ischemic preconditioning have received extensive studies, few have addressed the mechanisms associated with rapid ischemic postconditioning. We investigated whether ischemic tolerance induced by rapid preconditioning is regulated by the Akt survival signaling pathway. Stroke was generated by permanent occlusion of the left distal middle cerebral artery (MCA) plus 30 min or 1 h occlusion of the bilateral common carotid artery (CCA) in male rats. Rapid preconditioning performed 1h before stroke onset reduced infarct size by 69% in rats with 30 min CCA occlusion, but by only 19% with 1 h occlusion. After control ischemia with 30 min CCA occlusion, Western Blot showed that P-Akt was transiently increased while Akt kinase assay showed that Akt activity was decreased. Although preconditioning did not change P-Akt levels at 1h and 5h compared with control ischemia, it attenuated reduction in Akt activity at 5h in the penumbra. However, preconditioning did not change the levels of P-PDK1, P-PTEN, and P-GSK3β in the Akt pathway, all of which were decreased after stroke. At last, the PI3K kinase inhibitor, LY294002, completely reversed the protection from ischemic preconditioning. In conclusion, Akt contributes to the protection of rapid preconditionin against stroke.

Entities:  

Year:  2010        PMID: 21804899      PMCID: PMC3144475          DOI: 10.1007/s12975-010-0017-5

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  34 in total

1.  Regulation of Akt/PKB activation by tyrosine phosphorylation.

Authors:  R Chen; O Kim; J Yang; K Sato; K M Eisenmann; J McCarthy; H Chen; Y Qiu
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

2.  Insulin-stimulated protein kinase B phosphorylation on Ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase.

Authors:  M M Hill; M Andjelkovic; D P Brazil; S Ferrari; D Fabbro; B A Hemmings
Journal:  J Biol Chem       Date:  2001-05-23       Impact factor: 5.157

Review 3.  PI3K/Akt and apoptosis: size matters.

Authors:  Thomas F Franke; Christoph P Hornik; Lisa Segev; Grigoriy A Shostak; Chizuru Sugimoto
Journal:  Oncogene       Date:  2003-12-08       Impact factor: 9.867

4.  Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus.

Authors:  S Yano; M Morioka; K Fukunaga; T Kawano; T Hara; Y Kai; J Hamada ; E Miyamoto; Y Ushio
Journal:  J Cereb Blood Flow Metab       Date:  2001-04       Impact factor: 6.200

5.  Serine-threonine protein kinase Akt does not mediate ischemic tolerance after global ischemia in the gerbil.

Authors:  S Namura; I Nagata; H Kikuchi; M Andreucci; A Alessandrini
Journal:  J Cereb Blood Flow Metab       Date:  2000-09       Impact factor: 6.200

6.  Rapid tolerance to focal cerebral ischemia in rats is attenuated by adenosine A1 receptor antagonist.

Authors:  Michiko Nakamura; Kazuhiko Nakakimura; Mishiya Matsumoto; Takefumi Sakabe
Journal:  J Cereb Blood Flow Metab       Date:  2002-02       Impact factor: 6.200

7.  Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice.

Authors:  N Noshita; A Lewén; T Sugawara; P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2001-12       Impact factor: 6.200

8.  Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity.

Authors:  Heng Zhao; Midori A Yenari; Danye Cheng; Robert M Sapolsky; Gary K Steinberg
Journal:  J Neurochem       Date:  2003-05       Impact factor: 5.372

Review 9.  Ischemic tolerance and endogenous neuroprotection.

Authors:  Ulrich Dirnagl; Roger P Simon; John M Hallenbeck
Journal:  Trends Neurosci       Date:  2003-05       Impact factor: 13.837

Review 10.  Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.

Authors:  Roel Nusse
Journal:  Development       Date:  2003-11       Impact factor: 6.868

View more
  21 in total

1.  Lithium treatment reduces brain injury induced by focal ischemia with partial reperfusion and the protective mechanisms dispute the importance of akt activity.

Authors:  Tetsuya Takahashi; Gary K Steinberg; Heng Zhao
Journal:  Aging Dis       Date:  2012-02-08       Impact factor: 6.745

2.  Phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 may not always represent its kinase activity in a rat model of focal cerebral ischemia with or without ischemic preconditioning.

Authors:  T Takahashi; G K Steinberg; H Zhao
Journal:  Neuroscience       Date:  2012-02-11       Impact factor: 3.590

3.  Propofol Prevents Hippocampal Neuronal Loss and Memory Impairment in Cerebral Ischemia Injury Through Promoting PTEN Degradation.

Authors:  Xin Chen; Ye-Mu Du; Feng Xu; Dai Liu; Yuan-Lin Wang
Journal:  J Mol Neurosci       Date:  2016-08-01       Impact factor: 3.444

Review 4.  From rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemia.

Authors:  Heng Zhao; Chuancheng Ren; Xingmiao Chen; Jiangang Shen
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

5.  Repetitive ischemic preconditioning attenuates inflammatory reaction and brain damage after focal cerebral ischemia in rats: involvement of PI3K/Akt and ERK1/2 signaling pathway.

Authors:  Xian-kun Tu; Wei-zhong Yang; Jian-ping Chen; Yan Chen; Quan Chen; Ping-ping Chen; Song-sheng Shi
Journal:  J Mol Neurosci       Date:  2014-10-22       Impact factor: 3.444

6.  Isoflurane delays the development of early brain injury after subarachnoid hemorrhage through sphingosine-related pathway activation in mice.

Authors:  Orhan Altay; Yu Hasegawa; Prativa Sherchan; Hidenori Suzuki; Nikan H Khatibi; Jiping Tang; John H Zhang
Journal:  Crit Care Med       Date:  2012-06       Impact factor: 7.598

7.  Phosphodiesterase 10A Is a Critical Target for Neuroprotection in a Mouse Model of Ischemic Stroke.

Authors:  Mustafa C Beker; Ahmet B Caglayan; Serdar Altunay; Elif Ozbay; Nilay Ates; Taha Kelestemur; Berrak Caglayan; Ulkan Kilic; Thorsten R Doeppner; Dirk M Hermann; Ertugrul Kilic
Journal:  Mol Neurobiol       Date:  2021-11-04       Impact factor: 5.590

8.  Neferine Protects Against Brain Damage in Permanent Cerebral Ischemic Rat Associated with Autophagy Suppression and AMPK/mTOR Regulation.

Authors:  Jirakhamon Sengking; Chio Oka; Piyawadee Wicha; Nuttapong Yawoot; Jiraporn Tocharus; Waraluck Chaichompoo; Apichart Suksamrarn; Chainarong Tocharus
Journal:  Mol Neurobiol       Date:  2021-09-08       Impact factor: 5.590

9.  PRAS40 plays a pivotal role in protecting against stroke by linking the Akt and mTOR pathways.

Authors:  Xiaoxing Xiong; Rong Xie; Hongfei Zhang; Lijuan Gu; Weiying Xie; Michelle Cheng; Zhihong Jian; Kristina Kovacina; Heng Zhao
Journal:  Neurobiol Dis       Date:  2014-02-27       Impact factor: 5.996

10.  Akt isoforms differentially protect against stroke-induced neuronal injury by regulating mTOR activities.

Authors:  Rong Xie; Michelle Cheng; Mei Li; Xiaoxing Xiong; Marcel Daadi; Robert M Sapolsky; Heng Zhao
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-14       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.